期刊文献+

MMP-3和VEGF在胰腺癌中的表达及临床意义 被引量:3

Clinical significance of matrix metalloproteinases-3 and vascular endothelial growth factor expression in pancreatic carcinoma
暂未订购
导出
摘要 目的:探讨MMP-3和VEGF蛋白在胰腺癌组织中的表达及其与胰腺癌临床病理特征、预后及胰腺癌组织中血管新生的关系.方法:用免疫组织化学检测了56例手术切除的胰腺癌组织和正常胰腺组织中MMP-3、VEGF的蛋白表达和微血管密度,并请相关专业人员进行微血管密度计数分析.结果:在56例胰腺癌标本中有42例MMP-3(75.00%)和38例VEGF(67.85%)蛋白的表达阳性,明显高于正常胰腺组织.MMP-3和VEGF的阳性表达呈正相关(χ2=30.42,P<0.01).MMP-3在临床分期较晚和有淋巴结转移的胰腺癌中呈高表达.56例胰腺癌组织中的微血管密度与MMP-3、VEGF蛋白的阳性表达有关(tVEGF=3.67,P<0.01;tMMP-3=3.05,P<0.01).结论:MMP-3和VEGF可能通过相互促进的表达,促进胰腺癌组织中新生血管的形成,可能在胰腺癌的发生发展中起到重要作用.MMP-3对预测肿瘤的早期转移有一定的临床意义.而VEGF的相对低表达与临床所见胰腺癌在增强CT的低密度低动脉供血可能有关联. AIM:To investigate the expression of vascular endothelial growth factor(VEGF)and matrix metalloproteinases-3(MMP-3)in pancreatic carcinoma(PC)and to analyze their relationship with tumor angiogenesis,invasion and metastasis.METHODS:The protein expression of VEGF and MMP-3 and microvessel density(MVD) were detected by immunohistochemistry in 56 PC specimens and 56 normal pancreatic tissue specimens.RESULTS:The positive rates of both MMP-3 and VEGF were significantly higher in PC than in normal pancreatic tissue(75.00%vs 3.57%,67.85%vs 1.78%,both P〈0.01).There was a positive correlation between the expression of VEGF and that of MMP-3.Higher expression of MMP-3 was detected in late-stage PC and PC with lymph node metastasis.The expression of VEGF was correlated with clinical stage(P 〈0.05).MVD was correlated with expression of MMP-3 and VEGF in PC(both P〈0.05).CONCLUSION:MMP-3 and VEGF may promote tumor angiogenesis and play an important role in the development and progression of PC.Detection of MMP-3 expression could be used to predict early metastasis of PC.Lower expression of VEGF may be related to lower arterial blood supply in PC.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第15期1574-1578,共5页 World Chinese Journal of Digestology
基金 黑龙江省自然科学基金资助项目 No.ZJY0704-01~~
关键词 基质金属蛋白酶3 血管内皮生长因子 胰腺癌 Matrix metalloproteinases-3 Vascular endothelial growth factor Pancreatic carcinoma
  • 相关文献

参考文献30

  • 1Gress TM, Müller-Pillasch F, Lerch MM, Friess H, Büchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995; 62: 407-413.
  • 2Hui L, Desen W, Zhizhong P, Lijing C, Xiaojun W, Zhenhai L, Tai K. Expression and Biological Significance of Leptin, Leptin Receptor, VEGF, and CD34 in Colorectal Carcinoma. Cell Biochem Biophys 2010 Dec 16. [Epub ahead of print] PubMed.
  • 3Volm M, Koom?gi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 1997; 74: 64-68.
  • 4Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
  • 5Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227: 821-831.
  • 6李志伟,冯玉泉,顾万清,周宁新,张文智,黄志强.胰头癌外科疗效的临床分析[J].中华肝胆外科杂志,2006,12(2):92-94. 被引量:9
  • 7Maschuw K, Fendrich V, Langer P, Volland C, Ramaswamy A, Bartsch DK. Impact of CT-based diagnostic imaging on management and outcome of nonfunctioning pancreatic tumors. Langenbecks Arch Surg 2011 Feb 12. [Epub ahead of print] PubMed.
  • 8Schmid RM. [Pancreatic cancer]. Praxis (Bern 1994) 2006; 95: 1709-1712 PubMed.
  • 9李春龙,崔云甫,杜雪飞,邰升,钟翔宇.VEGF和MMP-9在胰腺癌侵袭转移中的表达及临床意义[J].世界华人消化杂志,2008,16(9):1012-1016. 被引量:21
  • 10Bogoevski D, Yekebas EF, Schurr P, Kaifi JT, Kutup A, Erbersdobler A, Pantel K, Izbicki JR. Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg 2004; 240: 993-1000; discussion 1000-1001.

二级参考文献27

  • 1郑英键,王文龙.胰腺导管癌扩大根治及其术式的探讨——胰大部切除术抑全胰切除术[J].中华肝胆外科杂志,1998,4(5):286-288. 被引量:1
  • 2李志伟,冯玉泉,顾万清,周宁新,张文智,黄志强.胰头癌外科疗效的临床分析[J].中华肝胆外科杂志,2006,12(2):92-94. 被引量:9
  • 3Nakao A,Harada A,Nonami T,et al.Clinical significance of portal invasion by pancreatic head carcinoma.Surgery,1995,117:50-55.
  • 4Moosa AR.Pancreatic cancer.Approach to diagnosis,selection for surgery and choice of operation.Cancer,1982,50:2689-2698.
  • 5Trede MS,Schwail G,Saeger HD.Survival after pancreatoduodenectomy 118 consecutive resections without an operative mortality.Ann Surg,1990,211:447-458.
  • 6Sener SF,Premgen A,Merok HR,et al.Pancreatic cancer:a report of treatment and survival trends for 100313 patients dignosed from 1985-1995 using the National Cancer Database.J AmColl Surg,1999,189:1-6.
  • 7Ishikawa O,Ohhigashi H,Saaski Y,et al.Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.Ann Surg,1988,208:215.
  • 8Knoll MR, Rudnitzki D, Sturm J, Manegold BC, Post S, Jaeger TM. Correlation of postoperative survival and angiogenic growth factors in pancreatic carcinoma. Hepatogastroenterology 2001; 48:1162-1165
  • 9Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, Koyanagi Y. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metaUoproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer, Pancreas 2002; 24:169-178
  • 10Bachler P, Reber HA, Buchler M, Shrinkante S,Buchler MW, Friess H, Semenza GL, Hines OJ. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003; 26:56-64

共引文献33

同被引文献39

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部